معرفی
Dr. Dong Yang is an Assistant Professor in the Department of Pharmaceutical Sciences within the College of Pharmacy and Health Sciences at St. John's University. His research focuses on overcoming drug resistance in cancer therapies, particularly targeting ABC transporters and leveraging natural products to enhance treatment efficacy. He explores immunotherapy strategies, such as CAR-T cell therapy, and investigates tumor microenvironment dynamics to improve patient outcomes.
- Affiliations: St. John's University, College of Pharmacy and Health Sciences, Department of Pharmaceutical Sciences
Dr. Yang’s work spans multiple cancer types, including lymphoma, breast cancer, and gastrointestinal cancers. His contributions include developing novel therapeutic combinations to combat multidrug resistance and advancing understanding of molecular mechanisms underlying cancer progression. He has published extensively on topics like RNA methylation, ABC transporter inhibition, and the application of natural products in oncology.
His research bridges basic science and translational medicine, aiming to translate findings into clinical applications. Key areas of interest include metabolic reprogramming in tumors, immune cell dysfunction in cancer, and the role of pharmacogenomics in personalized therapy.
Dr. Yang collaborates on preclinical studies of drug candidates and contributes to drug discovery programs targeting specific cancer pathways. His work has implications for improving treatment strategies in hematologic malignancies and solid tumors.
